Eisai
4523.T
#2215
Rank
โ‚น767.20 B
Marketcap
โ‚น2,719
Share price
0.27%
Change (1 day)
17.07%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): โ‚น73.02

According to Eisai's latest financial reports the company's current EPS (TTM) is โ‚น78.08. an increase over its 2024 EPS that were of โ‚น88.02.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025โ‚น98.4611.85%
2024โ‚น88.02-32.63%
2023โ‚น130.665.52%
2022โ‚น123.82-74.01%
2021โ‚น476.38-66.58%
2020โ‚น1,42598.24%
2019โ‚น718.9417.01%
2018โ‚น614.4237.78%
2017โ‚น445.95-27.62%
2016โ‚น616.1435.33%
2015โ‚น455.29-2.82%
2014โ‚น468.51-27.66%
2013โ‚น647.69-27.49%
2012โ‚น893.28-12.67%
2011โ‚น1,02388.08%
2010โ‚น543.88-11.06%
2009โ‚น611.53-390.15%
2008-โ‚น210.77-127.78%
2007โ‚น758.8011.78%
2006โ‚น678.844.38%
2005โ‚น650.397.4%
2004โ‚น605.6043.03%
2003โ‚น423.4225.09%
2002โ‚น338.4852.67%
2001โ‚น221.7069.76%
2000โ‚น130.60